These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9461180)
21. Oral DNA vaccination with the polyprotein gene of infectious bursal disease virus (IBDV) delivered by the attenuated Salmonella elicits protective immune responses in chickens. Li L; Fang W; Li J; Huang Y; Yu L Vaccine; 2006 Aug; 24(33-34):5919-27. PubMed ID: 16769159 [TBL] [Abstract][Full Text] [Related]
22. Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium. Eo SK; Yoon HA; Aleyas AG; Park SO; Han YW; Chae JS; Lee JH; Song HJ; Cho JG FEMS Immunol Med Microbiol; 2006 Aug; 47(3):451-61. PubMed ID: 16872383 [TBL] [Abstract][Full Text] [Related]
23. Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids. Bauer H; Darji A; Chakraborty T; Weiss S Gene Ther; 2005 Feb; 12(4):364-72. PubMed ID: 15616604 [TBL] [Abstract][Full Text] [Related]
24. Oral immunization against enteric infections using inactivated bacteria. A review. Mochmann H; Ocklitz HW Acta Microbiol Acad Sci Hung; 1974; 21(1-2):3-10. PubMed ID: 4613138 [No Abstract] [Full Text] [Related]
25. A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model. Zheng B; Woo PC; Ng M; Tsoi H; Wong L; Yuen K Vaccine; 2001 Oct; 20(1-2):140-7. PubMed ID: 11567758 [TBL] [Abstract][Full Text] [Related]
26. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines. Dietrich G; Kolb-Mäurer A; Spreng S; Schartl M; Goebel W; Gentschev I Vaccine; 2001 Mar; 19(17-19):2506-12. PubMed ID: 11257384 [TBL] [Abstract][Full Text] [Related]
27. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria. Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891 [TBL] [Abstract][Full Text] [Related]
28. Prophylactic tumor vaccination: comparison of effector mechanisms initiated by protein versus DNA vaccination. Zöller M; Christ O J Immunol; 2001 Mar; 166(5):3440-50. PubMed ID: 11207302 [TBL] [Abstract][Full Text] [Related]
29. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Hohmann EL; Oletta CA; Loomis WP; Miller SI Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2904-8. PubMed ID: 7708746 [TBL] [Abstract][Full Text] [Related]
30. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium. Jiang H; Hu Y; Yang M; Liu H; Jiang G Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901 [TBL] [Abstract][Full Text] [Related]
31. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Dietrich G; Bubert A; Gentschev I; Sokolovic Z; Simm A; Catic A; Kaufmann SH; Hess J; Szalay AA; Goebel W Nat Biotechnol; 1998 Feb; 16(2):181-5. PubMed ID: 9487527 [TBL] [Abstract][Full Text] [Related]
32. Contribution of MHC class I-dependent immune mechanisms induced by attenuated recombinant Salmonella typhimurium secreting superoxide dismutase to protection against murine listeriosis. Grode L; Kaufmann SH; Hess J Vaccine; 2001 Apr; 19(23-24):3269-72. PubMed ID: 11312024 [TBL] [Abstract][Full Text] [Related]
33. Expression of Salmonella typhimurium and Escherichia coli flagellin protein and its functional characterization as an adjuvant. Makvandi M; Teimoori A; Parsa Nahad M; Khodadadi A; Cheshmeh MGD; Zandi M Microb Pathog; 2018 May; 118():87-90. PubMed ID: 29530809 [TBL] [Abstract][Full Text] [Related]
34. Expression of heterologous antigens in Salmonella Typhimurium vaccine vectors using the in vivo-inducible, SPI-2 promoter, ssaG. McKelvie ND; Stratford R; Wu T; Bellaby T; Aldred E; Hughes NJ; Chatfield SN; Pickard D; Hale C; Dougan G; Khan SA Vaccine; 2004 Sep; 22(25-26):3243-55. PubMed ID: 15308346 [TBL] [Abstract][Full Text] [Related]
35. Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection. Pacheco LG; Mati VL; Castro TL; Dorella FA; Oliveira SC; Miyoshi A; de Melo AL; Azevedo V Parasitol Int; 2008 Dec; 57(4):506-8. PubMed ID: 18538627 [TBL] [Abstract][Full Text] [Related]
36. Improving live attenuated bacterial carriers for vaccination and therapy. Loessner H; Endmann A; Leschner S; Bauer H; Zelmer A; zur Lage S; Westphal K; Weiss S Int J Med Microbiol; 2008 Jan; 298(1-2):21-6. PubMed ID: 17702649 [TBL] [Abstract][Full Text] [Related]
37. Development of a novel in-water vaccination protocol for DNA adenine methylase deficient Salmonella enterica serovar Typhimurium vaccine in adult sheep. Mohler VL; Heithoff DM; Mahan MJ; Hornitzky MA; Thomson PC; House JK Vaccine; 2012 Feb; 30(8):1481-91. PubMed ID: 22214887 [TBL] [Abstract][Full Text] [Related]
38. Further studies on the use of Gal E mutants of Salmonella typhimurium in calves: oral vaccination and toxicity studies. Wray C; McLaren I Zentralbl Veterinarmed B; 1987 Feb; 34(1):22-9. PubMed ID: 3296569 [No Abstract] [Full Text] [Related]
39. Immunization of pigs to prevent disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium live negative-marker vaccine. Selke M; Meens J; Springer S; Frank R; Gerlach GF Infect Immun; 2007 May; 75(5):2476-83. PubMed ID: 17296750 [TBL] [Abstract][Full Text] [Related]
40. Optimization and delivery of plasmid DNA for vaccination. Jechlinger W Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]